PL3071192T3 - Związek kurkufenol do zastosowania w leczeniu nowotworu - Google Patents

Związek kurkufenol do zastosowania w leczeniu nowotworu

Info

Publication number
PL3071192T3
PL3071192T3 PL14815145T PL14815145T PL3071192T3 PL 3071192 T3 PL3071192 T3 PL 3071192T3 PL 14815145 T PL14815145 T PL 14815145T PL 14815145 T PL14815145 T PL 14815145T PL 3071192 T3 PL3071192 T3 PL 3071192T3
Authority
PL
Poland
Prior art keywords
curcufenol
cancer
compound
treatment
curcufenol compound
Prior art date
Application number
PL14815145T
Other languages
English (en)
Polish (pl)
Inventor
Wilfred A. Jefferies
Reinhard Gabathuler
Raymond Andersen
David Williams
Lilian NOHARA
Original Assignee
Cava Healthcare Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cava Healthcare Inc. filed Critical Cava Healthcare Inc.
Publication of PL3071192T3 publication Critical patent/PL3071192T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL14815145T 2013-11-20 2014-11-20 Związek kurkufenol do zastosowania w leczeniu nowotworu PL3071192T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361906817P 2013-11-20 2013-11-20
PCT/US2014/066543 WO2015077411A1 (en) 2013-11-20 2014-11-20 Curcuphenol compounds for increasing mhc-i expression
EP14815145.9A EP3071192B1 (en) 2013-11-20 2014-11-20 Curcuphenol compound for use in treating cancer

Publications (1)

Publication Number Publication Date
PL3071192T3 true PL3071192T3 (pl) 2020-06-29

Family

ID=52117996

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14815145T PL3071192T3 (pl) 2013-11-20 2014-11-20 Związek kurkufenol do zastosowania w leczeniu nowotworu

Country Status (10)

Country Link
US (4) US20150147314A1 (https=)
EP (2) EP3071192B1 (https=)
JP (4) JP6560215B2 (https=)
CN (1) CN106456572A (https=)
CA (1) CA2930156C (https=)
DK (1) DK3071192T3 (https=)
ES (1) ES2775577T3 (https=)
HU (1) HUE049301T2 (https=)
PL (1) PL3071192T3 (https=)
WO (1) WO2015077411A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2930156C (en) 2013-11-20 2023-11-07 Biommune Technologies Inc. Curcuphenol compounds for increasing mhc-i expression
EP3324967A4 (en) * 2015-07-22 2019-03-20 Prilenia Therapeutics Development Ltd. PRIDOPIDINE-BASED FORMULATIONS AND USE OF THE SAME
JP7520013B2 (ja) * 2018-12-17 2024-07-22 イントラ-セルラー・セラピーズ・インコーポレイテッド 置換複素環縮合γ-カルボリンの合成
WO2020154811A1 (en) 2019-01-31 2020-08-06 Cava Healthcare Inc. Compounds for increasing mhc-i expression and modulating histone deacetylase activity
TW202214245A (zh) * 2020-08-10 2022-04-16 國立彰化師範大學 雙非癌藥物用於製備治療癌症之醫藥組合物的用途
WO2022125339A2 (en) * 2020-12-07 2022-06-16 The Trustees Of Indiana University Methods to sensitize cancer cells to immune attack using atractylenolide i

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6261939A (ja) * 1985-09-10 1987-03-18 Yamanouchi Pharmaceut Co Ltd クルクフエノ−ル誘導体及びこれを含有する医薬
KR100439425B1 (ko) * 2001-03-22 2004-07-05 (주)바이오케어 잔토리졸을 포함하는 조성물 및 그 용도
KR100571159B1 (ko) * 2003-06-24 2006-04-18 박광균 항암제로 유발되는 독성의 억제제 및 이를 함유하는항암제 조성물
CA2688570A1 (en) * 2007-05-31 2008-12-04 F.P.L. Pharma Inc. Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
CA2930156C (en) 2013-11-20 2023-11-07 Biommune Technologies Inc. Curcuphenol compounds for increasing mhc-i expression

Also Published As

Publication number Publication date
CN106456572A (zh) 2017-02-22
DK3071192T3 (da) 2020-03-16
US20150147314A1 (en) 2015-05-28
EP3639815A1 (en) 2020-04-22
HUE049301T2 (hu) 2020-09-28
CA2930156A1 (en) 2015-05-28
EP3071192A1 (en) 2016-09-28
US20200375917A1 (en) 2020-12-03
CA2930156C (en) 2023-11-07
JP7071570B2 (ja) 2022-05-19
JP2021100982A (ja) 2021-07-08
US10751296B2 (en) 2020-08-25
JP2022093724A (ja) 2022-06-23
US20220062195A1 (en) 2022-03-03
WO2015077411A1 (en) 2015-05-28
JP2016539129A (ja) 2016-12-15
ES2775577T3 (es) 2020-07-27
JP6560215B2 (ja) 2019-08-14
US11197832B2 (en) 2021-12-14
US12011421B2 (en) 2024-06-18
JP2019196380A (ja) 2019-11-14
EP3071192B1 (en) 2019-12-18
US20170319508A1 (en) 2017-11-09

Similar Documents

Publication Publication Date Title
HUE057061T2 (hu) Kombinációs terápia rák kezelésére
GB2516814B (en) Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer
PL3542798T3 (pl) Aceklidyna do zastosowania w leczeniu starczowzroczności
HUE042188T2 (hu) Stimuláló eszköz
PL3623002T3 (pl) Cewnik
EP3035857A4 (en) ORTHODONTIC CLAMPS
GB201321729D0 (en) Therapeutic agents
GB201321733D0 (en) Therapeutic agents
GB201321728D0 (en) Therapeutic agents
GB201321730D0 (en) Therapeutic agents
GB201321732D0 (en) Therapeutic agents
EP2982331A4 (en) Treatment tool
LT3563837T (lt) Terapija bakteriofagu
IL244353A0 (en) Compounds and use for cancer treatment
PT3511004T (pt) Preparações combinadas para o tratamento de cancro
HUE053617T2 (hu) Kombinációs rákterápia azabiciklo vegyületet felhasználva
GB201321731D0 (en) Therapeutic agents
IL240499A0 (en) Caix stratification based cancer treatment
HRP20182041T1 (hr) Pripravci oksprenolola za liječenje raka
HUE047920T2 (hu) GD2-pozitív rák kezelésére szolgáló készítmények
PL3071192T3 (pl) Związek kurkufenol do zastosowania w leczeniu nowotworu
SI2892925T1 (sl) Kombinacijsko zdravljenje raka
DK3089778T3 (da) Ballonkateter
DK2976101T3 (da) Behandlingsfremgangsmåde
EP2958454A4 (en) MAGNETOTHERAPEUTIC BAND